Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer

Abstract Background Mammalian LEM-domain proteins (LEMs) are encoded by seven genes, including LAP2, EMD, LEMD1, LEMD2, LEMD3, ANKLE1, and ANKLE2. Though some LEMs were involved in various tumor progression, the expression and prognostic values of LEMs in prostate adenocarcinoma (PRAD) have yet to b...

Full description

Bibliographic Details
Main Authors: Tianzhen He, Yulian Zhang, Xueyu Li, Caihong Liu, Guanqun Zhu, Xinbao Yin, Zongliang Zhang, Kai Zhao, Zhenlin Wang, Peng Zhao, Ke Wang
Format: Article
Language:English
Published: BMC 2022-06-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-022-02640-z
_version_ 1817968925872226304
author Tianzhen He
Yulian Zhang
Xueyu Li
Caihong Liu
Guanqun Zhu
Xinbao Yin
Zongliang Zhang
Kai Zhao
Zhenlin Wang
Peng Zhao
Ke Wang
author_facet Tianzhen He
Yulian Zhang
Xueyu Li
Caihong Liu
Guanqun Zhu
Xinbao Yin
Zongliang Zhang
Kai Zhao
Zhenlin Wang
Peng Zhao
Ke Wang
author_sort Tianzhen He
collection DOAJ
description Abstract Background Mammalian LEM-domain proteins (LEMs) are encoded by seven genes, including LAP2, EMD, LEMD1, LEMD2, LEMD3, ANKLE1, and ANKLE2. Though some LEMs were involved in various tumor progression, the expression and prognostic values of LEMs in prostate adenocarcinoma (PRAD) have yet to be analyzed. Methods Herein, we investigated the expression, survival data, and immune infiltration levels of LEMs in PRAD patients from ATCG, TIMER, LinkedOmics, and TISIDB databases. We also further validated the mRNA and protein expression levels of ANKLE1, EMD, and LEMD2 in human prostate tumor specimens by qPCR, WB, and IHC. Results We found that all LEM expressions, except for that of LAP2, were markedly altered in PRAD compared to the normal samples. Among all LEMs, only the expressions of ANKLE1, EMD, and LEMD2 were correlated with advanced tumor stage and survival prognosis in PRAD. Consistent with the predicted computational results, the mRNA and protein expression levels of these genes were markedly increased in the PRAD group. We then found that ANKLE1, EMD, and LEMD2 expressions were markedly correlated with immune cell infiltration levels. High ANKLE1, EMD, and LEMD2 expressions predicted a worse prognosis in PRAD based on immune cells. DNA methylation or/and copy number variations may contribute to the abnormal upregulation of ANKLE1, EMD, and LEMD2 in PRAD. Conclusions Taken together, this study implied that ANKLE1, EMD, and LEMD2 were promising prognosis predictors and potential immunotherapy targets for PRAD patients.
first_indexed 2024-04-13T20:15:01Z
format Article
id doaj.art-de3851594f1f4b35b4d0bc149c4ce433
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-04-13T20:15:01Z
publishDate 2022-06-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-de3851594f1f4b35b4d0bc149c4ce4332022-12-22T02:31:44ZengBMCWorld Journal of Surgical Oncology1477-78192022-06-0120111610.1186/s12957-022-02640-zCollective analysis of the expression and prognosis for LEM-domain proteins in prostate cancerTianzhen He0Yulian Zhang1Xueyu Li2Caihong Liu3Guanqun Zhu4Xinbao Yin5Zongliang Zhang6Kai Zhao7Zhenlin Wang8Peng Zhao9Ke Wang10Institute of Special Environmental Medicine, Nantong UniversityDepartment of Gynecology, The Affiliated Hospital of Qingdao University, Qingdao UniversityDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao UniversityWestern Administrative Office Center, Qingdao West Coast New District Health BureauDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao UniversityDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao UniversityDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao UniversityDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao UniversityDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao UniversityFaculty of Sport Science and Coaching, Universiti Pendidikan Sultan IdrisDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao UniversityAbstract Background Mammalian LEM-domain proteins (LEMs) are encoded by seven genes, including LAP2, EMD, LEMD1, LEMD2, LEMD3, ANKLE1, and ANKLE2. Though some LEMs were involved in various tumor progression, the expression and prognostic values of LEMs in prostate adenocarcinoma (PRAD) have yet to be analyzed. Methods Herein, we investigated the expression, survival data, and immune infiltration levels of LEMs in PRAD patients from ATCG, TIMER, LinkedOmics, and TISIDB databases. We also further validated the mRNA and protein expression levels of ANKLE1, EMD, and LEMD2 in human prostate tumor specimens by qPCR, WB, and IHC. Results We found that all LEM expressions, except for that of LAP2, were markedly altered in PRAD compared to the normal samples. Among all LEMs, only the expressions of ANKLE1, EMD, and LEMD2 were correlated with advanced tumor stage and survival prognosis in PRAD. Consistent with the predicted computational results, the mRNA and protein expression levels of these genes were markedly increased in the PRAD group. We then found that ANKLE1, EMD, and LEMD2 expressions were markedly correlated with immune cell infiltration levels. High ANKLE1, EMD, and LEMD2 expressions predicted a worse prognosis in PRAD based on immune cells. DNA methylation or/and copy number variations may contribute to the abnormal upregulation of ANKLE1, EMD, and LEMD2 in PRAD. Conclusions Taken together, this study implied that ANKLE1, EMD, and LEMD2 were promising prognosis predictors and potential immunotherapy targets for PRAD patients.https://doi.org/10.1186/s12957-022-02640-zLEM-domain proteinsProstate adenocarcinomaImmune infiltrationSurvival prognosisGene mutations
spellingShingle Tianzhen He
Yulian Zhang
Xueyu Li
Caihong Liu
Guanqun Zhu
Xinbao Yin
Zongliang Zhang
Kai Zhao
Zhenlin Wang
Peng Zhao
Ke Wang
Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer
World Journal of Surgical Oncology
LEM-domain proteins
Prostate adenocarcinoma
Immune infiltration
Survival prognosis
Gene mutations
title Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer
title_full Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer
title_fullStr Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer
title_full_unstemmed Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer
title_short Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer
title_sort collective analysis of the expression and prognosis for lem domain proteins in prostate cancer
topic LEM-domain proteins
Prostate adenocarcinoma
Immune infiltration
Survival prognosis
Gene mutations
url https://doi.org/10.1186/s12957-022-02640-z
work_keys_str_mv AT tianzhenhe collectiveanalysisoftheexpressionandprognosisforlemdomainproteinsinprostatecancer
AT yulianzhang collectiveanalysisoftheexpressionandprognosisforlemdomainproteinsinprostatecancer
AT xueyuli collectiveanalysisoftheexpressionandprognosisforlemdomainproteinsinprostatecancer
AT caihongliu collectiveanalysisoftheexpressionandprognosisforlemdomainproteinsinprostatecancer
AT guanqunzhu collectiveanalysisoftheexpressionandprognosisforlemdomainproteinsinprostatecancer
AT xinbaoyin collectiveanalysisoftheexpressionandprognosisforlemdomainproteinsinprostatecancer
AT zongliangzhang collectiveanalysisoftheexpressionandprognosisforlemdomainproteinsinprostatecancer
AT kaizhao collectiveanalysisoftheexpressionandprognosisforlemdomainproteinsinprostatecancer
AT zhenlinwang collectiveanalysisoftheexpressionandprognosisforlemdomainproteinsinprostatecancer
AT pengzhao collectiveanalysisoftheexpressionandprognosisforlemdomainproteinsinprostatecancer
AT kewang collectiveanalysisoftheexpressionandprognosisforlemdomainproteinsinprostatecancer